Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
PACE-AL
1 other identifier
interventional
70
1 country
2
Brief Summary
The purpose of this study is to test a new preventive and restorative intervention for patients with acute leukaemia undergoing consolidation chemotherapy, to measure and delineate the patients' treatment related symptom burden and to explore the effect of the intervention on length of hospital stay, duration of sick leave and return to work status. Further, to examine the relationship of the symptom profile with clinical indicators, physiological response, physical performance and survival.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2011
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2011
CompletedStudy Start
First participant enrolled
June 1, 2011
CompletedFirst Posted
Study publicly available on registry
July 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2015
CompletedDecember 2, 2015
November 1, 2015
2.9 years
May 10, 2011
November 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Six Minute Walk Distance 6MWD
Change in distance in meter
Change from baseline in 6MWD at 12 weeks
Secondary Outcomes (8)
Estimated VO2 max Aastrand test
Change from baseline in VO2 Aastrand test at 12 weeks
Timed chair stand
Change from baseline in timed chair stand at 12 weeks
Timed biceps curl
Change from baseline in timed bicep curl at 12 weeks
EORTC QLQ-C30
Change from baseline in EORTC QLQ-C30 at 12 weeks
FACT-An
Change from baseline in FACT-An at 12 weeks
- +3 more secondary outcomes
Study Arms (2)
Exercise based multimodal intervention
EXPERIMENTALThe intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme
Control Group
NO INTERVENTIONControl group receives usual care
Interventions
The intervention is initiated early, during treatment (consolidation) in the intra-hospital setting and continues for two successive treatment series (12 weeks). The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and health-promoting consultation combined with an unsupervised in-home walking and progressive relaxation programme.
Eligibility Criteria
You may qualify if:
- Patients that are able to speak Danish \> 18 years and newly diagnosed with acute leukæmia (MDS, AML, CMML, APL or ALL)
- Normal EKG, blood pressure and pulse
- Signed informed written consent
You may not qualify if:
- Medical reason that contraindicates physical activity
- Patients diagnosed with a symptomatic cardial disease
- Documented bone metastasis
- Cognitively or emotionally unstable
- Unable to read or write in Danish
- Patients unable to carry out baseline tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitetshospitalernes Center for Sygeplejelead
- University of Copenhagencollaborator
- Novo Nordisk A/Scollaborator
- Danish Cancer Societycollaborator
- Lundbeck Foundationcollaborator
Study Sites (2)
Copenhagen University Hospital Rigshospital
Copenhagen, DK 2100, Denmark
Herlev Hospital
Herlev, DK 2730, Denmark
Related Publications (2)
Jarden M, Moller T, Christensen KB, Kjeldsen L, Birgens HS, Adamsen L. Multimodal intervention integrated into the clinical management of acute leukemia improves physical function and quality of life during consolidation chemotherapy: a randomized trial 'PACE-AL'. Haematologica. 2016 Jul;101(7):e316-9. doi: 10.3324/haematol.2015.140152. Epub 2016 Apr 1. No abstract available.
PMID: 27036163DERIVEDJarden M, Moller T, Kjeldsen L, Birgens H, Christensen JF, Bang Christensen K, Diderichsen F, Hendriksen C, Adamsen L. Patient Activation through Counseling and Exercise--Acute Leukemia (PACE-AL)--a randomized controlled trial. BMC Cancer. 2013 Oct 2;13:446. doi: 10.1186/1471-2407-13-446.
PMID: 24083543DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Jarden, Ph.D.
UCSF and CIRE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
May 10, 2011
First Posted
July 28, 2011
Study Start
June 1, 2011
Primary Completion
May 1, 2014
Study Completion
May 1, 2015
Last Updated
December 2, 2015
Record last verified: 2015-11